| Description | GSK706 is a novel effective agonist of the GPR119. |
| Synonyms | GSK 706, GSK-706 |
| molecular weight | 471.57 |
| Molecular formula | C23H29N5O4S |
| CAS | 1032824-43-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Taylor A, Rothstein D, Rudd CE. Small-Molecule Inhibition of PD-1 Transcription Is an Effective Alternative to Antibody Blockade in Cancer Therapy. Cancer Res. 2018 Feb 1;78(3):706-717. doi: 10.1158/0008-5472.CAN-17-0491. Epub 2017 Oct 20. PubMed PMID: 29055015. 2. Abberley L. Outsourcing of bioanalysis at GSK: a hybrid approach with a robust support model. Bioanalysis. 2017 Aug;9(15):1139-1144. doi: 10.4155/bio-2017-0062. Epub 2017 Aug 1. PubMed PMID: 28762760. 3. Zafar A, Hasan R, Nizamuddin S, Mahmood N, Mukhtar S, Ali F, Morrissey I, Barker K, Torumkuney D. Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15. J Antimicrob Chemother. 2016 May;71 Suppl 1:i103-9. doi: 10.1093/jac/dkw076. PubMed PMID: 27048578; PubMed Central PMCID: PMC4890355. 4. Park SJ, Jin ML, An HK, Kim KS, Ko MJ, Kim CM, Choi YW, Lee YC. Emodin induces neurite outgrowth through PI3K/Akt/GSK-3β-mediated signaling pathways in Neuro2a cells. Neurosci Lett. 2015 Feb 19;588:101-7. doi: 10.1016/j.neulet.2015.01.001. Epub 2015 Jan 3. PubMed PMID: 25562207. |